Drug Trial Radar · NCT02626299
Assessment of DHA On Reducing Early Preterm Birth
Last checked: Nov 19, 2026Latest source record: Mar 30, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,100
Actual
Start
Jun 8, 2016
Primary completion
Oct 5, 2020
Study completion Oct 5, 2020
Sponsor
- Lead sponsor
- University of Kansas Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Cincinnati; Ohio State University; Nationwide Children's Hospital
- First posted
- Dec 10, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- Female only, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if giving a larger amount of DHA than currently included in some prenatal supplements can reduce early preterm birth (birth before 34 weeks of pregnancy).
Conditions
- Preterm Birth
Interventions
Docosahexaenoic acid - 800mg/dayDrug
All participants will take 1000 mg/DHA per day (1 capsule will be labeled with 200 mg; 2 capsules will be masked with 400 mg each)
Docosahexaenoic acid - 200mg/dayDrug
The control group will receive 1-capsule containing 200 mg DHA/d.
PlaceboOther
Participants will receive 2 capsules (masked) containing half soybean oil and half corn oil equaling 800 mg.The soybean and corn oil combination does not contain DHA.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurrence of Early Preterm Birth (<34 weeks gestation)Time frame: Baseline to 34 Weeks
- Occurrence of Early Preterm Birth (<34 weeks gestation)Time frame: Baseline to 34 weeks
- Maternal and infant adverse and serious adverse eventsTime frame: Enrollment to 30 days past last birth
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
University of Kansas Medical Center
Kansas City, Kansas
University of Cincinnati
Cincinnati, Ohio
Ohio State University
Columbus, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.